Huaren Pharmaceutical announced that the company's chairman Chen Zhiguo and vice presidents Zhang Xinzhong, Hou Ruipeng, Wang Junhong, Yu Jie, and Feng Xinguang plan to jointly establish a partnership to increase their holdings within three months from the date of disclosure of the increase plan through centralized bidding. The total amount of increase in holdings will not be less than 10 million yuan, of which Chen Zhiguo will increase their holdings by 5 million yuan, and the remaining five will each be 1 million yuan. There is no price range for this increase in holdings. The funding source is personal capital. The holder of the increase promised not to reduce its holdings of the company's shares during the holdings increase period and within the statutory period, and within 12 months after the increase is completed. This increase in holdings will not lead to a change in the company's control, and there is a risk of uncertainty in the implementation of the holdings increase plan.

Huaren Pharmaceutical announced that the company's chairman Chen Zhiguo and vice presidents Zhang Xinzhong, Hou Ruipeng, Wang Junhong, Yu Jie, and Feng Xinguang plan to jointly establish a partnership to increase their holdings within three months from the date of disclosure of the increase plan through centralized bidding. The total amount of increase in holdings will not be less than 10 million yuan, of which Chen Zhiguo will increase their holdings by 5 million yuan, and the remaining five will each be 1 million yuan. There is no price range for this increase in holdings. The funding source is personal capital. The holder of the increase promised not to reduce its holdings of the company's shares during the holdings increase period and within the statutory period, and within 12 months after the increase is completed. This increase in holdings will not lead to a change in the company's control, and there is a risk of uncertainty in the implementation of the holdings increase plan.